Bide Pharmatech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Bide Pharmatech Co., Ltd.

Why is Bide Pharmatech Co., Ltd. ?

Positive results in Sep 25

NET SALES(Q) Highest at CNY 351.58 MM
RAW MATERIAL COST(Y) Fallen by -6.78% (YoY)
DEBTORS TURNOVER RATIO(HY) Highest at 4.88 times

With ROE of 6.97%, it has a very attractive valuation with a 3.56 Price to Book Value

Over the past year, while the stock has generated a return of -1.47%, its profits have risen by 76.3% ; the PEG ratio of the company is 0.7
At the current price, the company has a high dividend yield of 0.5

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Bide Pharmatech Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Bide Pharmatech Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Bide Pharmatech Co., Ltd.

2.09%

1.14

56.05%

China Shanghai Composite

16.01%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.00%

EBIT Growth (5y)

27.71%

EBIT to Interest (avg)

67.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.17

Sales to Capital Employed (avg)

0.52

Tax Ratio

23.78%

Dividend Payout Ratio

68.18%

Pledged Shares

Institutional Holding

ROCE (avg)

14.29%

ROE (avg)

5.99%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.56

EV to EBIT

40.01

EV to EBITDA

31.26

EV to Capital Employed

6.11

EV to Sales

5.01

PEG Ratio

0.67

Dividend Yield

0.49%

ROCE (Latest)

15.28%

ROE (Latest)

6.97%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

NET SALES(Q)

Highest at CNY 351.58 MM

RAW MATERIAL COST(Y)

Fallen by -6.78% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.88 times

PRE-TAX PROFIT(Q)

Highest at CNY 58.71 MM

NET PROFIT(Q)

Highest at CNY 46.32 MM

EPS(Q)

Highest at CNY 0.54

-3What is not working for the Company

INTEREST(9M)

At CNY 4.62 MM has Grown at 9.27%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.89 times

Here's what is working for Bide Pharmatech Co., Ltd.

Net Sales

Highest at CNY 351.58 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Net Sales

At CNY 351.58 MM has Grown at 26.69%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 58.71 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 58.71 MM has Grown at 60.65%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 46.32 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.54

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio

Highest at 4.88 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -6.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Bide Pharmatech Co., Ltd.

Interest

At CNY 4.62 MM has Grown at 9.27%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 0.89 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio